Page 2,229«..1020..2,2282,2292,2302,231..2,2402,250..»

Will stem cell therapy help cure spinal cord injury?

Posted: December 18, 2013 at 7:41 am

PUBLIC RELEASE DATE:

17-Dec-2013

Contact: Press Office biologypress@plos.org Public Library of Science

A systematic survey of the scientific literature shows that stem cell therapy can have a statistically significant impact on animal models of spinal cord injury, and points the way for future studies.

Spinal cord injuries are mostly caused by trauma, often incurred in road traffic or sporting incidents, often with devastating and irreversible consequences, and unfortunately having a relatively high prevalence (250,000 patients in the USA; 80% of cases are male). High-profile campaigners like the late actor Christopher Reeve, himself a victim of sports-related spinal cord injury, have placed high hopes in stem cell transplantation. But how likely is it to work?

This question is addressed in a paper published 17th December in the open access journal PLOS Biology by Ana Antonic, David Howells and colleagues from the Florey Institute and the University of Melbourne, Australia, and Malcolm MacLeod and colleagues from the University of Edinburgh, UK.

Stem cell therapy aims to use special regenerative cells (stem cells) to repopulate areas of damage that result from spinal cord injuries, with the hope of improving the ability to move ("motor outcomes") and to feel ("sensory outcomes") beyond the site of the injury. Many studies have been performed that involve animal models of spinal cord injury (mostly rats and mice), but these are limited in scale by financial, practical and ethical considerations. These limitations hamper each individual study's statistical power to detect the true effects of the stem cell implantation.

This new study gets round this problem by conducting a "meta-analysis" a sophisticated and systematic cumulative statistical reappraisal of many previous laboratory experiments. In this case the authors assessed 156 published studies that examined the effects of stem cell treatment for experimental spinal injury in a total of about 6000 animals.

Overall, they found that stem cell treatment results in an average improvement of about 25% over the post-injury performance in both sensory and motor outcomes, though the results can vary widely between animals. For sensory outcomes the degree of improvement tended to increase with the number of cells introduced scientists are often reassured by this sort of "dose response", as it suggests a real underlying biologically plausible effect.

The authors went on to use their analysis to explore the effects of bias (whether the experimenters knew which animals were treated and which untreated), the way that the stem cells were cultured, the way that the spinal injury was generated, and the way that outcomes were measured. In each case, important lessons were learned that should help inform and refine the design of future animal studies. The meta-analysis also revealed some surprises that should provoke further investigation there was little evidence of any beneficial sensory effects in female animals, for example, and it didn't seem to matter whether immunosuppressive drugs were administered or not.

Read more:
Will stem cell therapy help cure spinal cord injury?

Posted in Cell Therapy, Stem Cell Therapy | Comments Off on Will stem cell therapy help cure spinal cord injury?

With new multimillion-dollar grants, UCLA scientists take stem cell research to patients

Posted: December 18, 2013 at 7:40 am

PUBLIC RELEASE DATE:

16-Dec-2013

Contact: Shaun Mason smason@mednet.ucla.edu 310-206-2805 University of California - Los Angeles

Scientists from UCLA are now bringing their groundbreaking stem cell science directly to patients in two exciting new clinical trials scheduled to begin in early 2014, thanks to funding from California's stem cell agency.

The new grants to researchers at UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, which total nearly $21 million, were announced Dec. 12 at a meeting of the California Institute of Regenerative Medicine (CIRM) Citizen's Oversight Committee. They are apart of the state agency's Disease Team Therapy Development III initiative.

A team led by UCLA's Dr. Dennis Slamon and Dr. Zev Wainberg was awarded nearly $7 million for a clinical trial that will test a new drug targeting cancer stem cells, and UCLA's Dr. Donald Kohn received almost $14 million for a clinical trial that will focus on stem-cell gene therapy for sickle cell disease.

"The CIRM support demonstrates that our multidisciplinary center is at the forefront of translating basic scientific research into new drug and cellular therapies that will revolutionize medicine," said Dr. Owen Witte, director of the UCLA Broad Stem Cell Research Center.

Dennis Slamon and Zev Wainberg: Targeting solid tumor stem cells

This clinical trial builds on Slamon's previous work, partially funded by CIRM, with Wainberg and Dr. Tak Mak, director of the Campbell Family Institute at the University Health Network in Toronto, aimed at developing a drug that targets those stem cells thought to initiate solid cancer tumors.

The AmericanCanadian collaborative team will lead this first in-human Phase 1 trial testing their new therapy, which has received investigational new-drug approval from the U.S. Food and Drug Administration and Health Canada, Canada's therapeutic regulatory agency. The project has been approved to begin enrolling patients in both the U.S. and Canada.

Read more:
With new multimillion-dollar grants, UCLA scientists take stem cell research to patients

Posted in Stem Cell Therapy | Comments Off on With new multimillion-dollar grants, UCLA scientists take stem cell research to patients

Persuasive- Stem Cell Research – Video

Posted: December 18, 2013 at 6:41 am


Persuasive- Stem Cell Research

By: Shelby Patterson

See the original post:
Persuasive- Stem Cell Research - Video

Posted in Stem Cell Research | Comments Off on Persuasive- Stem Cell Research – Video

1. PHAM Before the First Course Stem Cells Treatment (before) – Video

Posted: December 17, 2013 at 1:41 am


1. PHAM Before the First Course Stem Cells Treatment (before)
Before the first stem cells treatment, PHAM can not walk and stand. Cerebral Palsy.

By: Cells Center China

See the original post:
1. PHAM Before the First Course Stem Cells Treatment (before) - Video

Posted in Stem Cell Videos | Comments Off on 1. PHAM Before the First Course Stem Cells Treatment (before) – Video

Stem Cells and You – Video

Posted: December 17, 2013 at 1:41 am


Stem Cells and You
Education on Stem Cells.

By: Andrew Trybull

See the rest here:
Stem Cells and You - Video

Posted in Stem Cell Videos | Comments Off on Stem Cells and You – Video

3. Treat Cerebral Palsy Children with Stem Cells (after treatment) – Video

Posted: December 17, 2013 at 1:41 am


3. Treat Cerebral Palsy Children with Stem Cells (after treatment)
With the development of medical technology, there are still many cerebral palsy children all over the world. Zhe Zhe, male, 5 years old. He was admitted for ...

By: Cells Center China

Read the original post:
3. Treat Cerebral Palsy Children with Stem Cells (after treatment) - Video

Posted in Stem Cell Videos | Comments Off on 3. Treat Cerebral Palsy Children with Stem Cells (after treatment) – Video

Stem cells therapy in Mexico Testimony-Carmen1 – Video

Posted: December 17, 2013 at 1:41 am


Stem cells therapy in Mexico Testimony-Carmen1
http://a1stemcells.com Testimony after 5 embryonic stem cells IV injections for a rejuvenation study.

By: Cure4Cancers

See more here:
Stem cells therapy in Mexico Testimony-Carmen1 - Video

Posted in Stem Cell Videos | Comments Off on Stem cells therapy in Mexico Testimony-Carmen1 – Video

Kidney grown from stem cells by Australian scientists

Posted: December 16, 2013 at 10:57 pm

Scientists are hoping to increase the size of future kidneys and believe the resulting organs will boost research and allow cheaper, faster testing of drugs. Within the next three to five years, the artificial organs could be used to allow doctors to repair damaged kidneys within the body, rather than letting diseases develop before proceeding with a transplant.

The engineered kidney was developed by a team of Australian scientists led by the University of Queensland's Institute for Molecular Bioscience.

Professor Wainwright said the process for developing the kidney was "like a scientific approach to cooking". The scientists methodically examined which genes were switched on and off during kidney development and then manipulated the skin cells into embryonic stem cells which could "self-organise" and form complex human structures.

"The [researchers] spent years looking at what happens if you turn this gene off and this one on," he said. "You can eventually coax these stem cells through a journey they [the cells] go through various stages and then think about being a kidney cell and eventually pop together to form a little piece of kidney."

The research could eventually help address the demand for transplant organs and improve medical testing of new drugs for patients with kidney disease.

Human kidneys are particularly susceptible to damage during trials, which makes finding effective medicines costly and time-consuming.

Professor Melissa Little, from the University of Queensland, said scientists could try to grow full-grown kidneys for transplants or even "clusters of mini kidneys" that could be transplanted to boost patients' renal functions. But she told The Australian she believed such developments were still more than a decade away.

Visit link:
Kidney grown from stem cells by Australian scientists

Posted in Stem Cells | Comments Off on Kidney grown from stem cells by Australian scientists

Kidney Grown From Stem Cells For The First Time, Australian Scientists Call Breakthrough ‘An Amazing Process’

Posted: December 16, 2013 at 10:57 pm

The breakthrough marks a major advance in treating kidney disease and more avenues in bioengineering human organs. Researchers published their findings in the journal Nature Cell Biology, following their success in making human skin cells form a functioning "mini-kidney" with a width of only a few millimeters.

During self-organization, different types of cells arrange themselves with respect to each other to create the complex structures that exist within an organ, in this case, the kidney, Professor Melissa Little of University of Queenslands Institute for Molecular Bioscience (IMB), who led the study, said in a statement. The fact that such stem cell populations can undergo self-organization in the laboratory bodes well for the future of tissue bioengineering to replace damaged and diseased organs and tissues.

While it may be a while until the process can be used in human trials, Little says it could be a major development in treating chronic kidney disease.

One in three Australians is at risk of developing chronic kidney disease, and the only therapies currently available are kidney transplant and dialysis, Little said. Only one in four patients will receive a donated organ, and dialysis is an ongoing and restrictive treatment regime.

The engineered kidney is a first for science.

"This is the first time anybody has managed to direct stem cells into the functional units of a kidney," Professor Brandon Wainwright, from the University of Queensland, told The Telegraph. "It is an amazing process it is like a Lego building that puts itself together."

Scientists were able to make the kidney by identifying genes that remained active and inactive during kidney development. They were then able to alter the genes into embryonic cells that allowed them to self-organize into the human organ.

"The [researchers] spent years looking at what happens if you turn this gene off and this one on," Wainwright said. "You can eventually coax these stem cells through a journey they [the cells] go through various stages and then think about being a kidney cell and eventually pop together to form a little piece of kidney."

Little predicts the stem cell kidneys could one day be used to make human kidney transplants, or a cluster of mini kidneys used to boost renal function in patients.

Read the original here:
Kidney Grown From Stem Cells For The First Time, Australian Scientists Call Breakthrough ‘An Amazing Process’

Posted in Stem Cells | Comments Off on Kidney Grown From Stem Cells For The First Time, Australian Scientists Call Breakthrough ‘An Amazing Process’

Regenerative medicine: Mayo Clinic and collaborators develop new tool for transplanting stem cells

Posted: December 16, 2013 at 10:57 pm

PUBLIC RELEASE DATE:

16-Dec-2013

Contact: Jennifer Schutz newsbureau@mayo.edu 507-284-5005 Mayo Clinic

ROCHESTER, Minn. -- Mayo Clinic researchers and colleagues in Belgium have developed a specialized catheter for transplanting stem cells into the beating heart. The novel device includes a curved needle and graded openings along the needle shaft, allowing for increased distribution of cells. The result is maximized retention of stem cells to repair the heart. The findings appear in the journal Circulation: Cardiovascular Interventions.

"Although biotherapies are increasingly more sophisticated, the tools for delivering regenerative therapies demonstrate a limited capacity in achieving high cell retention in the heart," says Atta Behfar, M.D., Ph.D., a Mayo Clinic cardiology specialist and lead author of the study. "Retention of cells is, of course, crucial to an effective, practical therapy."

Researchers from the Mayo Clinic Center for Regenerative Medicine in Rochester and Cardio3 Biosciences in Mont-Saint-Guibert, Belgium, collaborated to develop the device, beginning with computer modeling in Belgium. Once refined, the computer-based models were tested in North America for safety and retention efficiency.

What's the significance?

This new catheter is being used in the European CHART-1 clinical trials, now underway. This is the first Phase III trial to regenerate hearts of patients who have suffered heart attack damage. The studies are the outcome of years of basic science research at Mayo Clinic and earlier clinical studies with Cardio3 BioSciences and Cardiovascular Centre in Aalst, Belgium, conducted between 2009 and 2010.

###

The development of the catheter and subsequent studies were supported by Cardio3 BioSciences; Walloon Region General Directorate for Economy, Employment & Research; Meijer Lavino Foundation for Cardiac Research Aalst (Belgium); the National Institutes of Health; Grainger Foundation; Florida Heart Research Institute; Marriott Heart Disease Research Program; and the Mayo Clinic Center for Regenerative Medicine.

Read more:
Regenerative medicine: Mayo Clinic and collaborators develop new tool for transplanting stem cells

Posted in Regenerative Medicine | Comments Off on Regenerative medicine: Mayo Clinic and collaborators develop new tool for transplanting stem cells

Page 2,229«..1020..2,2282,2292,2302,231..2,2402,250..»